Home » Slideshare - All Slideshows » The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

× Share this Presentation

Facebook
Twitter
Email
LinkedIn
Google+

Email Address

First Name

Last Name

Company

Title

Country

Thank you for registering!

Error - something went wrong!

The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

November 1, 2017

Share this Presentation
Facebook
Twitter
Email
LinkedIn
Google+

The Connected Journey™ of data-driven services powered by PAREXEL® Analytics

Previous Presentation

Getting to Approval Faster Through Technology Innovation

PAREXEL's Matt Neal joins experts from Microsoft and Allergan to discuss how innovations in technology can ...

Next Presentation

So, My FitBit is Clinical Trial Grade Right?

So, My FitBit is Clinical Trial Grade Right? by PAREXEL's Keith Wenzel

Most Recent Presentations

Seamless Dataflow with a Clinical Metadata Repository

Learn how PAREXEL's Clinical Metadata Repository can help improve the way you manage clinical trial data.

View Presentation

FDA Initiatives Under The 21st Century Cures Act

Learn about FDA's priorities for implementing The 21st Century Cures Act and how they will impact clinical research from PAREXEL Consulting experts.

View Presentation

Exploring Ways to Enhance Evidence Generation & Communication Planning

PAREXEL experts explore key aspects of successful evidence generation and communication plans and how to apply them in your organization.

View Presentation

Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpoints

PAREXEL Consulting experts detail operational aspects of independent reviews in the context of immunotherapy clinical trials.

View Presentation

Development Considerations Comparing Major Markets Including US, EU, Japan and China

PAREXEL Consulting experts compare regulatory requirements in major drug development markets including the US, EU, Japan and China.

View Presentation

Understanding Different Stakeholder Requirements Throughout Commercialization

Learn how to use Real World Evidence (RWE) to bridge the evidence gap between regulators and payers.

View Presentation

RIM & IDMP Synergies

View the presentation to learn about RIM & IDMP synergies.

View Presentation

The Art and Science of Productive FDA Meetings

View the presentation to learn key strategies for optimizing meetings with the FDA.

View Presentation

Generating Evidence to Drive Patient Access

View this presentation to learn strategies for generating evidence that will help your product clear market access hurdles.

View Presentation

RIM & IDMP Synergies

View the presentation to learn about RIM & IDMP synergies.

View Presentation

Regulatory Strategy In Emerging Markets

PAREXEL Principal Consultant Angela McGillivary discusses commercial considerations, clinical development, regulatory requirements, submission and post approval strategies in emerging markets

View Presentation

Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions

PAREXEL's Michelle Hoiseth on how pharmas can leverage Real-World Data to help improve patient outcomes.

View Presentation

You're Hot Then You're Cold - Temperature Management & RTSM Integration

PAREXEL's Colette Thorold discusses the latest innovations in monitoring temperature-controlled medications in clinical trials.

View Presentation

Latin America´s Role In Clinical Studies

Drug manufacturers are looking to emerging markets like Latin America to fuel long-term success. View this PAREXEL Consulting presentation to learn more.

View Presentation

Data Management Roles, Process and Technologies In Risk Based Study Execution

PAREXEL's Patrick Nadolny on the benefits of data management expertise, tech, and process to efficient Risk Based Study Execution (RBSE).

View Presentation

Why Strategy Is Not Enough

Janice Haigh, PAREXEL's Worldwide Head of Pricing & Market Access, on how clinical research organizations simplify the journey from strategy to results.

View Presentation

Getting to Approval Faster Through Technology Innovation

PAREXEL's Matt Neal joins experts from Microsoft and Allergan to discuss how innovations in technology can help patients by reducing the time and expense of bringing life-saving treatments to market.

View Presentation

So, My FitBit is Clinical Trial Grade Right?

So, My FitBit is Clinical Trial Grade Right? by PAREXEL's Keith Wenzel

View Presentation

Early Phase Oncology Trials: A Study in Adaptation

Early Phase Oncology Trials: A Study in Adaptation by Sharon Murray

View Presentation

Developing Drugs �in the New Era of Personalized Medicines

Developing Drugs �in the New Era of Personalized Medicines by Anita Nelsen - Head of Genomic Medicine, Sr. Director, PAREXEL International and Dr. Sy Pretorius - Sr. Vice President, Chief Scientific O

View Presentation

Return to Home